Tag Archives: The Stem Cell Blog

More than 60 US clinics have sold unproven stem cell therapies for heart failure – New York Post

Continue reading

2017-07-26 NEWS

New York Post

More than 60 US clinics have sold unproven stem cell therapies for heart failure
New York Post
Researchers found 61 centers offering stem cell therapies for heart failure as of last year in the US alone, including five that claimed to have performed more than 100 procedures. Only nine centers required copies of patients’ medical records and just

Continue reading

2017-07-26 NEWS

Technology Networks

Shedding Light on How Tumors Become Resistant to Immunotherapy
Technology Networks
In tumor immunotherapy, the body’s own defense system is activated against the tumor cells. However, for the majority of patients, the tumor cells become resistant to the treatments used. Researchers at the University of Zurich and the University

and more »

Continue reading

2017-07-26 NEWS

Technology Networks

Shedding Light on How Tumors Become Resistant to Immunotherapy
Technology Networks
In tumor immunotherapy, the body’s own defense system is activated against the tumor cells. However, for the majority of patients, the tumor cells become resistant to the treatments used. Researchers at the University of Zurich and the University

Continue reading

2017-07-26 NEWS

High Point Observer

Controversial CRISPR paper earns second editorial note
Retraction Watch (blog)
When “Unexpected mutations after CRISPR–Cas9 editing in vivo” was published May 30, it immediately drew criticism from many of the top scientists working with CRISPR, including those associated with companies seeking to develop CRISPR-based …
$-0.42 EPS Expected for Intellia Therapeutics (NTLA), Colony Financial (CLNY) Sentiment Is 0.92High Point Observer
The Intellia Therapeutics, Inc. (NASDAQ:NTLA) Given Consensus Rating of “Buy” by AnalystsBangaloreWeekly

all 5 news articles »

Continue reading

2017-07-26 NEWS

High Point Observer

Controversial CRISPR paper earns second editorial note …
Retraction Watch (blog)
Against the authors’ objections, Nature Methods has added an expression of concern to a 2017 paper that drew fire for suggesting a common gene editing …
$-0.42 EPS Expected for Intellia Therapeutics (NTLA), Colony …High Point Observer
Intellia Therapeutics (NTLA) Reaches $17.68 After 3.00% Up Move …HuronReport
-$0.42 EPS Expected for Intellia Therapeutics, Inc. (NASDAQ:NTLA …Sports Perspectives
BangaloreWeekly
all 5 news articles »